The global arthroscopy instruments market is projected to reach USD 5.61 billion by 2022 from USD 4.17 billion in 2017, at a CAGR of 6.1% during the forecast period. Rising number of sports injuries, growing aging population; technological advancements in arthroscopy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of this market.

The high incidence of sport-related injuries; technological advancements in arthroscopy products; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=238516643

In the last three years, the arthroscopy instrument market has witnessed several product launches and developments. The major technological changes happened in visualization systems and arthroscopes. For instance, in 2017, DePuy launched the PURVUE – Next-Generation high-definition visualization system. Similarly, Olympus launched the ENDOEYE 3D video telescope. In 2015, FDA approved nuvis, a single-use arthroscope manufactured by Integrated Endoscopy in the US. Similarly, in 2016, NeoScope received marketing clearance from FDA for its single-use, Neo-arthroscope Digital Video Arthroscopic System.

In this report, the market has been segmented on the basis of product, end user, and region.

On the basis of product, the market is segmented into arthroscopic implants, arthroscopes, visualization system, RF ablation system, motorized shavers, and fluid management system. The arthroscopes market is expected to grow at the highest CAGR during the forecast period owing to increasing number of arthroscopy surgeries and rising adoption of single-use/disposable arthroscopes.

Based on applications, arthroscopy instruments market is segmented into knee arthroscopy, shoulder arthroscopy, and other arthroscopy applications including hip, foot, ankle, elbow and wrist arthroscopy. In the coming years, growth in the other arthroscopy segment is expected to be fueled by advancements in the field of hip arthroscopy. Being a more complicated surgery, the number of hip arthroscopy procedures is currently limited. However, the demand for, as well as the number of hip arthroscopy procedures, is expected to rise in the coming years as arthroscopic device manufacturers have begun developing specialized instrumentation for the same. Based on end users, the arthroscopy instruments market is segmented into hospitals and ambulatory surgery center & clinics. As most physicians and patients prefer ASCs owing to the cost advantages of performing arthroscopic surgeries in ASCs over hospitals, ambulatory surgery centers & clinics segment is expected to grow at the fastest CAGR during the forecast period.

Request for Sample Report:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=238516643

Based on region, the arthroscopy instrument market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia Pacific segment is expected to register the highest growth rate during the forecast period. In Asia Pacific region, China and Japan are estimated to hold the largest market share in 2017. This is attributed to the universal healthcare reimbursement scenario in Japan and largest patient pool in China. However, India is estimated to be the fastest growing country in the APAC region during the forecast period. The availability of skilled physicians and nurse practitioners and the low cost of surgeries and post-operative care in hospitals have fueled medical tourism in India. This, coupled with the rising geriatric population and improving healthcare infrastructure are the major factors driving the arthroscopy instruments market in this country.

The geographical regions mapped in the report are:

The report covers the Knee Arthroscopy Market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017, however, Asia Pacific is expected to register the highest growth rate during the forecast period. The growth of the Asia Pacific region is attributed to the growing patient pool and on-going positive changes in healthcare infrastructure in that region.

Some key players mentioned in the research report are:

The major players of the market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), CONMED (US), Zimmer Biomet (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India).

Speak to analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=238516643



About MarketsandMarkets

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain-points around revenues decisions